1990PubMedRequires access

Human liver fibroblast capacity for synthesizing interstitial collagenase in vitro.

Hervé Emonard, A. Guillouzo, C. M. Lapière, J.A. Grimaud

Open publisher page 20 citations

Abstract

si e s------------------------ABSTRACT------------------------- P4 initiates specifically the degradation of interstitial collagen types I-III. This enzyme is thus directly involved in the remodeling of the connective matrix. Fibroblasts are considered as the major source of interstitial collagenase in many tissues. However previous studies shown that liver fibroblasts did not spontaneously produce the enzyme. We have thus measured the steady-state levels of mRNA for interstitial procollagenase and quantified interstitial collagenase activity in cultured human liver fibroblasts, in presence or not of interleukin-1 or tumor necrosis factor. We demonstrate that human liver fibroblasts have the capacity for producing interstitial collagenase and that this production is regulated at a transcriptional step. We suggest that the liver fibroblast could represent a key cell for therapeutic strategies of fibrosis reversal.

About this research paper

What this paper is about

si e s------------------------ABSTRACT------------------------- P4 initiates specifically the degradation of interstitial collagen types I-III. This enzyme is thus directly involved in the remodeling of the connective matrix. Fibroblasts are considered as the major source of interstitial collagenase in many tissues. However previous studies shown that liver fibroblasts did not spontaneously produce the enzyme. We have thus measured the steady-state levels of mRNA for interstitial procollagenase and quantified interstitial collagenase activity in cultured human liver fibroblasts, in presence or not of interleukin-1 or tumor necrosis factor. We demonstrate that human liver fibroblasts have the capacity for producing interstitial collagenase and that this production is regulated at a transcriptional step. We suggest that the liver fibroblast could represent a key cell for therapeutic strategies of fibrosis reversal.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

si e s------------------------ABSTRACT------------------------- P4 initiates specifically the degradation of interstitial collagen types I-III. This enzyme is thus directly involved in the remodeling of the connective matrix. Fibroblasts are considered as the major source of interstitial collagenase in many tissues. However previous studies shown that liver fibroblasts did not spontaneously produce the enzyme. We have thus measured the steady-state levels of mRNA for interstitial procollagenase and quantified interstitial collagenase activity in cultured human liver fibroblasts, in presence or not of interleukin-1 or tumor necrosis factor. We demonstrate that human liver fibroblasts have the capacity for producing interstitial collagenase and that this production is regulated at a transcriptional step. We suggest that the liver fibroblast could represent a key cell for therapeutic strategies of fibrosis reversal.

Key concepts: Collagenase, Fibroblast, Interstitial collagenase, Connective tissue, In vitro, Fibrosis, Interstitial cell, Hepatic stellate cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Human liver fibroblast capacity for synthesizing interstitial collagenase in vitro. — Research Paper | ScholarLens